Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Corient Private Wealth LLC

Corient Private Wealth LLC boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 0.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 258,612 shares of the medical research company’s stock after acquiring an additional 1,665 shares during the period. Corient Private Wealth LLC owned 0.09% of Agilent Technologies worth $34,742,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Massachusetts Financial Services Co. MA raised its stake in shares of Agilent Technologies by 3.5% during the third quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company’s stock worth $2,314,784,000 after purchasing an additional 525,214 shares during the last quarter. State Street Corp raised its position in Agilent Technologies by 1.2% during the 3rd quarter. State Street Corp now owns 12,819,897 shares of the medical research company’s stock worth $1,903,498,000 after buying an additional 158,175 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Agilent Technologies by 0.4% in the 3rd quarter. Geode Capital Management LLC now owns 6,948,679 shares of the medical research company’s stock worth $1,028,241,000 after acquiring an additional 30,610 shares during the period. Cantillon Capital Management LLC boosted its holdings in shares of Agilent Technologies by 0.5% in the fourth quarter. Cantillon Capital Management LLC now owns 3,316,557 shares of the medical research company’s stock valued at $445,546,000 after acquiring an additional 17,627 shares in the last quarter. Finally, Van ECK Associates Corp increased its stake in shares of Agilent Technologies by 8.7% during the fourth quarter. Van ECK Associates Corp now owns 3,235,263 shares of the medical research company’s stock worth $434,625,000 after acquiring an additional 258,358 shares during the period.

Insider Transactions at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Agilent Technologies Trading Up 1.2 %

Agilent Technologies stock opened at $122.63 on Tuesday. The stock has a 50-day moving average price of $137.99 and a 200 day moving average price of $137.82. Agilent Technologies, Inc. has a 52 week low of $117.17 and a 52 week high of $155.35. The stock has a market cap of $34.96 billion, a PE ratio of 28.19, a P/E/G ratio of 3.40 and a beta of 1.11. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Equities research analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.81%. Agilent Technologies’s payout ratio is 22.76%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on A shares. Robert W. Baird lowered their price objective on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a report on Thursday, February 27th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. JPMorgan Chase & Co. cut their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, November 26th. Barclays upgraded shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and boosted their target price for the stock from $135.00 to $145.00 in a research report on Monday, February 10th. Finally, Bank of America cut their price target on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a report on Friday, December 13th. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $146.15.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.